December 9, 2025

Dynavax Technologies Corporation (DVAX) Stock Analysis: Navigating a 75% Potential Upside

For individual investors keeping a keen eye on the healthcare sector, Dynavax Technologies Corporation (NASDAQ: DVAX) presents an intriguing opportunity. The biopharmaceutical company, based in Emeryville, California, is known for..

89bio, Inc. (ETNB) Stock Analysis: Exploring a Potential 104% Upside with Innovative Biotech Solutions

89bio, Inc. (NASDAQ: ETNB) is carving out a niche in the biotech sector with its focus on liver and cardio-metabolic diseases. Headquartered in San Francisco, 89bio is at the forefront..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring an 81.99% Upside Potential in the Health Information Services Sector

GoodRx Holdings, Inc. (GDRX), a prominent player in the health information services industry, is making waves with an impressive potential upside of 81.99%. As a company dedicated to providing consumers..

ICU Medical, Inc. (ICUI): Investor Outlook Reveals 25.78% Potential Upside Amidst Robust Analyst Ratings

ICU Medical, Inc. (NASDAQ: ICUI) stands as a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $3.55 billion, the..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A 69% Potential Upside Beckons Investors

Beam Therapeutics Inc. (NASDAQ: BEAM), a rising star in the biotechnology sector, presents a captivating opportunity for investors keen on genetic medicine. With a market capitalization of $2.75 billion, Beam..

Vera Therapeutics, Inc. (VERA) Stock Analysis: A 53.57% Upside in the Biotech Sector

Vera Therapeutics, Inc. (NASDAQ: VERA), a promising player in the biotechnology sector, has caught the attention of investors with a noteworthy potential upside of 53.57%. As a clinical-stage biotechnology company,..

Dyne Therapeutics, Inc. (DYN): Investor Outlook with a Promising 65.82% Upside Potential

Investors with an eye on the biotechnology sector may find Dyne Therapeutics, Inc. (NASDAQ: DYN) an intriguing proposition. With a current market capitalization of $3.17 billion, Dyne Therapeutics, a clinical-stage..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Challenges in the Healthcare Sector

BGM Group Ltd. (BGM), a player in the healthcare sector specializing in drug manufacturing for both specialty and generic markets, presents a complex picture for potential investors. Operating within China..

Kestra Medical Technologies (KMTS): Investor Outlook with 51% Revenue Growth and 13.56% Potential Upside

Kestra Medical Technologies, Ltd. (KMTS), a promising player in the healthcare sector, is gaining attention from investors with its impressive revenue growth and potential upside. Specializing in wearable medical devices,..

Disc Medicine, Inc. (IRON) Stock Report: Analyst Ratings Signal Strong Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, is drawing significant attention in the healthcare sector for its innovative approach to treating serious hematologic diseases. With a market capitalization..

Arcellx, Inc. (ACLX) Stock Report: Exploring a 52.71% Potential Upside in Biotech Innovation

Arcellx, Inc. (NASDAQ: ACLX) is capturing investor attention in the biotechnology sector with its promising pipeline of immunotherapies aimed at tackling cancer and other incurable diseases. Positioned in the dynamic..

Neogen Corporation (NEOG) Stock Analysis: Healthcare Innovator with 35% Upside Potential

Neogen Corporation (NASDAQ: NEOG), a key player in the Healthcare sector, operates within the Diagnostics & Research industry, focusing on ensuring food and animal safety. With a market cap of..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 49% Upside Potential in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL), a notable player in the biotechnology sector, has captured investor attention with its innovative contributions to sports medicine and severe burn care. Headquartered in Cambridge, Massachusetts,..

NewAmsterdam Pharma (NAMS) Stock Report: A Biotech Powerhouse with 30.84% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a biopharmaceutical firm based in the Netherlands, has been capturing attention in the healthcare sector with its innovative clinical trials aimed at combating metabolic..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring the 18.80% Upside Potential

Investors eyeing opportunities in the healthcare sector may find Guardian Pharmacy Services, Inc. (GRDN) an intriguing prospect. With its focus on providing technology-enabled services to long-term healthcare facilities (LTCFs) in..

PROCEPT BioRobotics (PRCT) Stock Analysis: A Robotics Pioneer with 46.64% Potential Upside

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is carving out a niche in the healthcare sector, specifically within the medical devices industry. With a strategic focus on developing transformative surgical robotics solutions,..

Indivior PLC (INDV) Stock Analysis: A Look at the 3.43% Potential Upside and Strong Buy Ratings

Indivior PLC (INDV) stands out in the healthcare sector, focusing on specialty and generic drug manufacturing. Its core mission revolves around developing and delivering buprenorphine-based prescription drugs, primarily targeting opioid..

Artivion, Inc. (AORT) Stock Analysis: Unveiling a 17% Potential Upside in the Medical Devices Sector

For investors with a keen eye on the healthcare sector, Artivion, Inc. (AORT) presents an intriguing opportunity. As a key player in the medical devices industry, Artivion has a market..

Immunocore Holdings (IMCR) Stock Analysis: A 67.65% Potential Upside in the Biotech Sector

Immunocore Holdings plc (NASDAQ: IMCR) stands out in the biotechnology landscape with a compelling growth narrative that promises significant upside potential for investors. With a market capitalization of $1.93 billion,..

GRAIL, Inc. (GRAL) Stock Analysis: Analyzing the 5.21% Upside Potential in Healthcare Diagnostics

GRAIL, Inc. (NASDAQ: GRAL), a leader in the diagnostics and research sector of the healthcare industry, has captured the attention of investors with its innovative approach to multi-cancer early detection...

Search

Funds

December 9, 2025

Search

Funds

December 9, 2025

FTSE 100

Funds